By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AEterna Zentaris 

1405 Boul Du Parc-technologique

Quebec  Quebec  G1P 4P5  Canada
Phone: 418-652-8525 Fax: 418-652-0881


SEARCH JOBS








Company News
AEterna Zentaris (AEZS) Announces Zoptrex Presentation In Prostate Cancer At 2017 Genitourinary Cancers Symposium 2/15/2017 6:33:37 AM
AEterna Zentaris (AEZS) Announces Plans To Pursue FDA Registration Of Macrilen 2/13/2017 6:17:40 AM
AEterna Zentaris (AEZS) Announces Completion Of Zoptrex Pivotal Phase 3 Clinical Trial In Advanced Endometrial Cancer; Expects To Report Top-Line Results In April 2017 1/31/2017 11:26:54 AM
AEterna Zentaris (AEZS) Crashes on Disappointing Phase III Data 1/5/2017 5:52:01 AM
AEterna Zentaris (AEZS) Reports Third Quarter 2016 Financial And Operating Results 11/9/2016 11:05:43 AM
AEterna Zentaris (AEZS) Announces Closing Of US$7,560,000 Registered Direct Offering Of Common Shares And Warrants 11/1/2016 11:41:05 AM
AEterna Zentaris (AEZS) To Announce Third Quarter 2016 Financial And Operating Results On November 8, 2016 10/28/2016 12:27:45 PM
AEterna Zentaris (AEZS) Announces US$7,560,000 Registered Direct Offering Of Common Shares And Warrants 10/27/2016 10:57:17 AM
AEterna Zentaris (AEZS) Completes Patient Recruitment For Confirmatory Phase III Trial Of Macrilen 10/26/2016 10:17:49 AM
AEterna Zentaris (AEZS) And Specialised Therapeutics Asia Sign Exclusive License Agreement For The Potential Marketing Of Zoptrex In Australia And New Zealand 10/12/2016 11:35:30 AM
12345678910...
//-->